Newbury-based Arieso has launched a new software product aimed at enabling wireless network operators to assess return on investment on proposed capital projects.
London Technology Fund completed a partial exit this month from its investment in Dynamic IT Management Services – a company that develops specialist software for the foreign exchange market.
Wireless chip designer Frontier Silicon reported further progress this month, revealing that it has now shipped more than five million DAB integrated circuits and modules, as well as securing more than 10 design wins for its Venice 6 Wi-Fi radio solution.
Imperial College spinout EVO Electric has raised £1.5m to help it develop electrical motors and generators for the hybrid electric vehicle market.
Dr Andrew Spragg, chief executive officer and founder of Aquapharm Biodiscovery, has won a top Scottish award for innovation in recognition of the potential for an antibiotic compound developed by his company to combat infections such as MRSA. Dr Spragg has received the Gannochy Trust Innovation Award, which carries a £50,000 cash prize and a gold medal, from the Royal Society of Edinburgh
Newcastle-based e-Therapeutics plans to join London’s Alternative Investment Market in the near future. The drug discovery company owns candidate drugs in five therapeutic areas, which together represent a potential market of more than $80bn.
Two portfolio companies of technology transfer business Biofusion have been sold to a privatelyowned pharmaceutical company just days after Biofusion raised its equity holdings in both companies to 50%. The sales of Cardiff Biologicals and Cardiff ProTides to Morvus Technology means that Biofusion now has a remaining portfolio of 23 companies from its partnerships with Sheffield and Cardiff universities.
A Department of Trade and Industry-funded programme to develop materials to help complex surgical and regenerative medicine applications has proved a success, according to NovaThera – a Cambridge-based company involved in the programme.
Imperial College spinout deltaDOT has received a further £3m from investors, completing its fourth round of funding. The funds will be used to increase production capacity for the company’s ‘Peregrine’ system – a high performance capillary electrophoresis instrument for the separation of proteins, peptides, nucleic acids, small molecules and pathogens